Stimulation of GLP-1 Receptor Inhibits Methylglyoxal-Induced Mitochondrial Dysfunctions in H9c2 Cardiomyoblasts: Potential Role of Epac/PI3K/Akt Pathway-Reference-Cited by-同舟云学术

Stimulation of GLP-1 Receptor Inhibits Methylglyoxal-Induced Mitochondrial Dysfunctions in H9c2 Cardiomyoblasts: Potential Role of Epac/PI3K/Akt Pathway

Published:2020-05-29 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Nuamnaichati Narawat,Mangmool Supachoke,Chattipakorn Nipon,Parichatikanond Warisara

Funder

Thailand Research Fund

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference59 articles.

1. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways;Ban;Circulation,2008

2. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor;Ban;Endocrinology,2010

3. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice;Belke;Am. J. Physiol. Endocrinol. Metab.,2000

4. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart;Boudina;Circulation,2009

5. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress;Brouwers;Diabetologia,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets;Cell Biochemistry and Function;2024-09-03

2. The benefits of oral glucose-lowering agents: GLP-1 receptor agonists, DPP-4 and SGLT-2 inhibitors on myocardial ischaemia/reperfusion injury;European Journal of Pharmacology;2024-08

3. Unraveling the Cardiac Matrix: From Diabetes to Heart Failure, Exploring Pathways and Potential Medications;Biomedicines;2024-06-13

4. Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects;Pharmaceutics;2024-05-22

5. Evidence that tirzepatide protects against diabetes-related cardiac damages;Cardiovascular Diabetology;2024-03-30